Esophageal Dilation denied due to quantity / dose limits by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for esophageal dilation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Esophageal Dilation for Quantity Limits

BCBS imposes frequency and quantity limits on esophageal dilation — typically restricting the number of dilation sessions covered within a defined time period. When a patient requires more sessions than the plan's default limit, BCBS will deny the additional procedure as exceeding quantity limits. This denial is common in patients with refractory strictures, eosinophilic esophagitis, or conditions that require repeated dilation to maintain adequate luminal diameter. The limit in your plan's policy is the controlling number; you must review that policy to know exactly what threshold applies.

## Why This Denial Is Appealable

Quantity-limit denials are appealable when the clinical record demonstrates that the additional procedure is medically necessary and not duplicative. Gastroenterology societies recognize that some patients require more frequent dilation than a plan's default limit, and that withholding treatment creates genuine clinical risk. You are entitled to internal appeal under ERISA §503 or your state's insurance law, and to independent external review under ACA §2719 after exhausting internal remedies, generally within approximately four months of the final internal denial.

## Your Appeal Timeline

1. Obtain the denial letter and request the plan's operative coverage policy showing the specific quantity limit. 2. File a first-level internal appeal within the deadline shown on your Explanation of Benefits. 3. If denied internally, request external review within the window stated in the final denial letter.

## Documentation to Gather

• Diagnosis and etiology: Records confirming the underlying cause of recurrent stricturing (e.g., eosinophilic esophagitis, radiation injury, caustic injury, surgical anastomosis) — the cause directly supports the need for more frequent treatment.
• Prior dilation history with dates and outcomes: A table of every prior session, the diameter achieved, and how quickly symptoms recurred. This is the single most persuasive document in a quantity-limit appeal.
• Clinical severity at time of each denial: Weight, nutritional status, dysphagia severity scale scores, and any aspiration events documented in office notes.
• Treating physician's letter: A letter from your gastroenterologist explaining why the patient's condition requires dilation beyond the plan's default frequency, referencing applicable ACG or ASGE guidelines.
• Failure of alternatives: Documentation that any alternative management (dietary modification, medication, surveillance) has been tried and has not eliminated the need for re-dilation.

## Criteria-Mapping Structure

Review BCBS's coverage policy for the exact quantity limit and any exception criteria. Then:

| Plan Requirement or Exception Criterion | Your Chart Evidence | |---|---| | Underlying diagnosis qualifies for exception | Cite pathology/biopsy or imaging | | Prior dilations documented with outcomes | Cite procedure notes with dates | | Clinical necessity for additional session | Cite symptom recurrence timeline | | Physician recommends additional dilation | Cite prescriber medical-necessity letter |

A well-organized timeline of prior sessions paired with documented symptom recurrence gives the reviewer everything needed to approve an exception to the quantity limit.